ID29236A - Benzopiran-benzopiran dan benzoksepin-benzoksepin, komposisi-komposisi famaseutikal yang mengandungnya, dan proses penyiapannya - Google Patents

Benzopiran-benzopiran dan benzoksepin-benzoksepin, komposisi-komposisi famaseutikal yang mengandungnya, dan proses penyiapannya

Info

Publication number
ID29236A
ID29236A IDW00200101656A ID20011656A ID29236A ID 29236 A ID29236 A ID 29236A ID W00200101656 A IDW00200101656 A ID W00200101656A ID 20011656 A ID20011656 A ID 20011656A ID 29236 A ID29236 A ID 29236A
Authority
ID
Indonesia
Prior art keywords
famaseutical
benzoxins
benzopirans
compositions
beneficial
Prior art date
Application number
IDW00200101656A
Other languages
English (en)
Inventor
Michel Brunet
Jean J Zeiller
Jean J Berthelon
Francis Cintard
Gauy Augert
Daniel Guerrier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ID29236A publication Critical patent/ID29236A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/06—Peri-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
IDW00200101656A 1998-12-29 1999-12-20 Benzopiran-benzopiran dan benzoksepin-benzoksepin, komposisi-komposisi famaseutikal yang mengandungnya, dan proses penyiapannya ID29236A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9816574A FR2787789B1 (fr) 1998-12-29 1998-12-29 Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations

Publications (1)

Publication Number Publication Date
ID29236A true ID29236A (id) 2001-08-16

Family

ID=9534619

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101656A ID29236A (id) 1998-12-29 1999-12-20 Benzopiran-benzopiran dan benzoksepin-benzoksepin, komposisi-komposisi famaseutikal yang mengandungnya, dan proses penyiapannya

Country Status (19)

Country Link
US (1) US6596758B1 (id)
EP (1) EP1140893B1 (id)
JP (1) JP4607331B2 (id)
KR (1) KR100684088B1 (id)
CN (2) CN1173967C (id)
AU (1) AU759892B2 (id)
BR (1) BR9916633A (id)
CA (1) CA2356680C (id)
CZ (1) CZ300086B6 (id)
FR (1) FR2787789B1 (id)
HK (1) HK1047584B (id)
HU (1) HUP0104839A3 (id)
ID (1) ID29236A (id)
NO (1) NO20013242D0 (id)
PL (1) PL196524B1 (id)
RU (1) RU2228333C2 (id)
SK (1) SK9022001A3 (id)
WO (1) WO2000039113A1 (id)
ZA (1) ZA200106177B (id)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003029238A1 (en) * 2001-10-04 2003-04-10 Wyeth Chroman derivatives as 5-hydroxytryptamine-6 ligands
FR2845386B1 (fr) * 2002-10-07 2006-06-30 Merck Sante Sas Nouveaux derives metastables de benzoxepines utilisables dans le traitement des dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation
EP1598345A4 (en) * 2003-02-26 2006-03-22 Shanghai Inst Materia Medica BENZOPYRANE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USES THEREOF
KR101255074B1 (ko) 2003-10-01 2013-04-16 아돌로 코포레이션 스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법
US6887896B1 (en) * 2003-10-29 2005-05-03 Allergan, Inc. 7-[(7-Alkoxy)-chrom-3-en-6-yl]-heptatrienoic acid and 7-[(3-alkoxy)-5,6-dihydronaphthalen-2-yl]-heptatrienoic acid derivatives having serum glucose reducing activity
ES2272926T3 (es) * 2003-11-28 2007-05-01 Merck Sante Tratamiento de hiperuricemia.
SI1591434T1 (sl) * 2004-04-27 2007-10-31 Merck Sante Sas Novi 1-metoksi-2-fenil eteni za pripravo 5-karboksaldehid-2-3-dihidrobenzoksepina
SI1600446T1 (sl) * 2004-05-18 2008-04-30 Merck Sante Sas Novi derivati 3,3-dimetil-5-ciano-benzoksepina, ki so uporabljivi za pripravo derivatov 5-formil-benzoksepina
ATE518850T1 (de) * 2004-06-25 2011-08-15 Merck Sante Sas 5-alkenon-3,3-dimethyl-benzoxepinderivate und ihre verwendung in der herstellung von antidiabetischen pentadiensäuren
US20070021612A1 (en) * 2004-11-04 2007-01-25 University Of Notre Dame Du Lac Processes and compounds for preparing histone deacetylase inhibitors and intermediates thereof
US7235688B1 (en) 2004-11-04 2007-06-26 University Of Notre Dame Du Lac Process for preparing histone deacetylase inhibitors and intermediates thereof
BRPI0519013A2 (pt) * 2004-12-13 2009-11-03 Lilly Co Eli composto ou esteroisÈmeros únicos, misturas de esteroisÈmeros, sais, tautÈmeros ou pró-drogas destes farmaceuticamente aceitáveis, composição farmacêutica, e, uso de um composto
US20080146655A1 (en) * 2005-02-16 2008-06-19 Md Bioalpha Co., Ltd. Pharmaceutical Composition for the Treatment or Prevention of Diseases Involving Obesity, Diabetes, Metabolic Syndrome, Neuro-Degenerative Diseases and Mitochondria Dyfunction Diseases
US7598261B2 (en) * 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) * 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
JP2010503669A (ja) * 2006-09-12 2010-02-04 アドラー コーポレーション 認知機能の強化のためのｎ含有スピロ化合物の使用
CN101172978A (zh) * 2006-11-02 2008-05-07 中国人民解放军军事医学科学院毒物药物研究所 六元杂环化合物,其制备方法及其医药用途
EP2120925A4 (en) * 2007-03-16 2010-04-07 Novogen Res Pty Ltd AUTOPHAGIA INDUCTION METHOD
EP2306965B1 (en) * 2008-08-09 2015-12-02 Merck Patent GmbH Use of indole compounds as a cosmetic
WO2010017885A2 (en) * 2008-08-12 2010-02-18 Merck Patent Gmbh Use of 5-(7-methoxy-3,3-dimethyl-2,3-dihydro-1-benzoxepin-5-yl)-3-methyl- penta-2,4-dienoic acid as a cosmetic
WO2016140979A1 (en) * 2015-03-03 2016-09-09 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
WO2016140978A1 (en) 2015-03-03 2016-09-09 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
US10238655B2 (en) 2017-01-23 2019-03-26 Arizona Board Of Regents On Behalf Of Arizona State University Dihydroindene and tetrahydronaphthalene compounds
US10231947B2 (en) 2017-01-23 2019-03-19 Arizona Board Of Regents On Behalf Of Arizona State University Isochroman compounds and methods of use thereof
US10238626B2 (en) 2017-01-23 2019-03-26 Arizona Board Of Regents On Behalf Of Arizona State University Therapeutic compounds
CN108371712B (zh) * 2018-01-18 2020-12-25 华北理工大学 咖啡因与PPARγ激动剂联合制备AD药物中的用途
WO2022053416A1 (en) 2020-09-08 2022-03-17 Merck Patent Gmbh Improvement of water-holding capacity of skin by oxeglitazar

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5004744A (en) * 1988-12-13 1991-04-02 Bayer Aktiengesellschaft Pyridazinones as pesticides
EP0412939A3 (en) * 1989-08-11 1991-09-04 Ciba-Geigy Ag Certain benzopyran and benzothiopyran derivatives
US4946860A (en) * 1989-11-03 1990-08-07 Rorer Pharmaceutical Corporation Benzothiopyranyl derivatives as HMG-CoA reductase inhibitors
ATE163544T1 (de) * 1991-12-18 1998-03-15 Salk Inst For Biological Studi Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen
US5391569A (en) * 1992-09-29 1995-02-21 Adir Et Compagnie New chromene compounds having a triene side chain
DE69516903T2 (de) * 1994-12-30 2000-10-26 Ligand Pharmaceuticals, Inc. Retinoid trienverbindungen und verfahren
US5675033A (en) * 1995-06-06 1997-10-07 Allergan 2,4-pentadienoic acid derivatives having retinoid-like biological activity

Also Published As

Publication number Publication date
NO20013242L (no) 2001-06-28
FR2787789A1 (fr) 2000-06-30
ZA200106177B (en) 2002-12-24
HK1047584B (zh) 2005-05-27
KR100684088B1 (ko) 2007-02-16
EP1140893A1 (en) 2001-10-10
HUP0104839A2 (hu) 2002-04-29
WO2000039113A1 (en) 2000-07-06
SK9022001A3 (en) 2002-04-04
CN1554651A (zh) 2004-12-15
CZ300086B6 (cs) 2009-01-28
CN1359383A (zh) 2002-07-17
NO20013242D0 (no) 2001-06-28
HUP0104839A3 (en) 2003-01-28
AU759892B2 (en) 2003-05-01
PL349448A1 (en) 2002-07-29
CA2356680C (en) 2010-03-23
PL196524B1 (pl) 2008-01-31
CZ20012387A3 (cs) 2001-11-14
US6596758B1 (en) 2003-07-22
JP2003517449A (ja) 2003-05-27
EP1140893B1 (en) 2003-03-05
CN1173967C (zh) 2004-11-03
RU2228333C2 (ru) 2004-05-10
JP4607331B2 (ja) 2011-01-05
BR9916633A (pt) 2001-09-25
KR20010101339A (ko) 2001-11-14
HK1047584A1 (en) 2003-02-28
FR2787789B1 (fr) 2002-06-14
CA2356680A1 (en) 2000-07-06
CN1307171C (zh) 2007-03-28
AU2432900A (en) 2000-07-31

Similar Documents

Publication Publication Date Title
ID29236A (id) Benzopiran-benzopiran dan benzoksepin-benzoksepin, komposisi-komposisi famaseutikal yang mengandungnya, dan proses penyiapannya
ID30299A (id) Turunan oksazolidinon, proses pembuatannya dan komposisi farmasi yang mengandungnya
ID24929A (id) Turunan 2-aril-8-oksodihidropurin, proses pembuatannya, komposisi farmasinya yang mengandungnya, dan senyawa antaranya
ID17307A (id) Komposisi oral dan proses pembuatannya.
ID28728A (id) Komposisi dan proses pengkrepan
HUP0100221A3 (en) Sustained release compositions, process for producing the same and utilization thereof
ID26007A (id) Proses karbonilasi
ID29207A (id) Komposisi katalitis yang sesuai untuk proses fischer-tropsch
HUP9900163A3 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
GB9903216D0 (en) Preservative compounds,compositions and methods of making and using the same
HUP0200811A2 (en) Solid composition, its producing and using
AU3671099A (en) Methods and compositions pertaining to pd-loops
GB2338244B (en) A microbe composition, a method to prepare the same and uses thereof
ID23351A (id) PROSES PERSIAPAN PIRAZOLO[4,3-d]PIRIMIDIN-7ON DAN SENYAWA - ANTARANYA
ID28820A (id) Komposisi penolak air, proses pembuatan dan pemakainnya
GB9817235D0 (en) Compound,composition and use
ID22572A (id) Proses yang disempurnakan untuk pembuatan 3,5,5-trimetilsikloheksa-3-en-1-on (betha-isoforon) dengan isomerisasi 3,5,5-trimetilsikloheksa-2-en-1-on (alpha-isoforon) (ii)
GB2334721B (en) Cleansing composition
GB2336592B (en) Polymer for photoresist,photoresist composition containing the same,and preparation method thereof
ID18521A (id) Proses asetoksilasi olefin-olefin
ID23304A (id) Turunan-turunan diaza-spiro [3,5] nonana, proses pembuatan dan penggunaannya
GB9608485D0 (en) Compositions, processes and uses
GB9817236D0 (en) Compound,composition and use
AU1915399A (en) Cs-1 peptidomimetics, compositions and methods of using the same
ID22400A (id) Proses produksi untuk karet alam dan karet alam yang didapat melalui proses yang sama